Literature DB >> 31894081

The Laboratory Features of Congenital Hypothyroidism and Approach to Therapy.

Alyson Weiner1, Sharon Oberfield1, Patricia Vuguin1.   

Abstract

Congenital hypothyroidism (CH) is one of the most common preventable causes of intellectual disability. Thyroid hormone is required for normal brain development, but neonates with CH typically appear healthy at birth, which leads to delays in diagnosis and treatment. In developed countries, newborn screening programs have led to earlier diagnosis and treatment of CH, resulting in improved neurodevelopmental outcomes. Neonates with an abnormal newborn screen require prompt confirmatory serum thyroid function tests and treatment with thyroid hormone. Further evaluation for the etiology of CH should not delay treatment decisions.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Year:  2020        PMID: 31894081      PMCID: PMC7428150          DOI: 10.1542/neo.21-1-e37

Source DB:  PubMed          Journal:  Neoreviews        ISSN: 1526-9906


  32 in total

Review 1.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 2.  The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology.

Authors:  D Glinoer
Journal:  Endocr Rev       Date:  1997-06       Impact factor: 19.871

3.  Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas.

Authors:  Cynthia F Hinton; Katharine B Harris; Lynette Borgfeld; Margaret Drummond-Borg; Roger Eaton; Fred Lorey; Bradford L Therrell; Jill Wallace; Kenneth A Pass
Journal:  Pediatrics       Date:  2010-05       Impact factor: 7.124

Review 4.  Management of Fetal and Neonatal Graves' Disease.

Authors:  Juliane Léger
Journal:  Horm Res Paediatr       Date:  2016-12-16       Impact factor: 2.852

5.  Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy.

Authors:  V J Pop; J L Kuijpens; A L van Baar; G Verkerk; M M van Son; J J de Vijlder; T Vulsma; W M Wiersinga; H A Drexhage; H L Vader
Journal:  Clin Endocrinol (Oxf)       Date:  1999-02       Impact factor: 3.478

Review 6.  Endocrine manifestations of Down syndrome.

Authors:  Rachel Whooten; Jessica Schmitt; Alison Schwartz
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

Review 7.  Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings.

Authors:  R T Zoeller; J Rovet
Journal:  J Neuroendocrinol       Date:  2004-10       Impact factor: 3.627

Review 8.  Approach to the diagnosis and treatment of neonatal hypothyroidism.

Authors:  Stephen H LaFranchi
Journal:  J Clin Endocrinol Metab       Date:  2011-10       Impact factor: 5.958

Review 9.  Genetic causes of congenital hypothyroidism due to dyshormonogenesis.

Authors:  Helmut Grasberger; Samuel Refetoff
Journal:  Curr Opin Pediatr       Date:  2011-08       Impact factor: 2.856

Review 10.  Thyroid gland development and defects.

Authors:  Juergen Kratzsch; Ferdinand Pulzer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-02       Impact factor: 4.690

View more
  3 in total

Review 1.  Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions.

Authors:  Nadia Sawicka-Gutaj; Natalia Zawalna; Paweł Gut; Marek Ruchała
Journal:  Pharmacol Rep       Date:  2022-06-30       Impact factor: 3.919

2.  Mutation screening of eight genes and comparison of the clinical data in a Chinese cohort with congenital hypothyroidism.

Authors:  Liangshan Li; Xiaole Li; Xiaoyu Wang; Mengmeng Han; Dehua Zhao; Fang Wang; Shiguo Liu
Journal:  Endocrine       Date:  2022-09-20       Impact factor: 3.925

3.  Screening of Congenital Hypothyroidism in North-East Romania. Benefits and Messages for Further Improvement.

Authors:  D T Anton-Paduraru; S Bilha; E G Miftode; M L Iliescu; L Leustean; M C Ungureanu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.